Tracking RSV in young children at Turkish emergency departments
Part of Infections, Lungs & breathing clinical trials.
This study tracks young children under 5 who arrive at certain hospital emergency departments in Türkiye with RSV (a virus that causes colds and breathing trouble). By watching their symptoms and care, doctors hope to learn more about how RSV affects children and improve treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is under 5 years old when they visit the ER.
- A test (from a nose or throat swab) confirms they have RSV, a common winter virus that causes breathing problems.
- They come to a participating hospital's emergency room during the RSV season (2025-2026) for a problem like a bad cold, bronchiolitis, pneumonia, apnea, seizures, or heart inflammation.
- You (or the child's legal guardian) agree to sign a permission form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at information from patients who had RSV (a common virus that can cause breathing problems) and were treated at SEHA hospitals in Abu Dhabi. The goal is to understand how common RSV is and how it affects people, which could help improve care.
This study looks at how the bacteria in the gut and the immune system respond in infants hospitalized with severe RSV infection. It may help doctors understand why some babies get sicker and could lead to better treatments.
This study looks at how RSV (a common virus that can affect breathing) leads to illness in young children who come to the doctor with ear infections and/or breathing symptoms. It may help doctors better understand the “burden” RSV causes in both home/outpatient and hospital settings.
This study looks for markers in the blood that can tell how serious an RSV infection might become. If you are hospitalized with RSV and have breathing symptoms, this trial will follow your recovery and test for clues about your illness.
This study follows babies under 12 months old who are hospitalized with bronchiolitis to understand their treatment and outcomes. It includes tracking RSV testing and a new immunization called nirsevimab, which may help protect against severe illness.
This study tracks how respiratory syncytial virus (RSV)—a common respiratory infection in babies—affects children under 24 months in Ho Chi Minh City. Researchers want to understand how often RSV happens, how severe it is, and how it impacts families, so they can better prepare healthcare services.
Hear when a new Acute Bronchiolitis Due to Respiratory Syncytial Virus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.